metricas
covid
Clinics Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta...
Journal Information

Statistics

Follow this link to access the full text of the article

Original articles
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors
Marcio Barcellosa,b,1, Antonio Bragaa,b,c,1,
Corresponding author
antonio.braga@ufrj.br

Corresponding author.
, Matheus Machado Rechd, Solange Artimos de Oliveirab, Jose Mauro Madid, Sue Yazaki Sune, Jorge de Rezende-Filhoa, Kevin M. Eliasf, Neil S. Horowitzf, Ross S. Berkowitzf
a Centro de Doenças Trofoblásticas do Rio de Janeiro, Maternidade Escola da Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
b Postgraduate Program in Medical Sciences, Faculdade de Medicina, Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil
c Postgraduate Program in Applied Health Sciences, Universidade de Vassouras, Vassouras, RJ, Brazil
d Centro de Doenças Trofoblásticas de Caxias do Sul, Faculdade de Medicina, Universidade de Caxias do Sul, Caxias do Sul, RS, Brazil
e Department of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
f New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Read
1762
Times
was read the article
639
Total PDF
1123
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 98 29 127
2025 11 351 185 536
2025 10 93 49 142
2025 9 77 62 139
2025 8 93 48 141
2025 7 110 79 189
2025 6 92 64 156
2025 5 68 48 116
2025 4 59 23 82
2025 3 82 52 134

Follow this link to access the full text of the article